Anxiogenic properties of yohimbine
Authors:
- 1 July 1992
- journal article
- clinical trial
- Published by Springer Nature in European Archives of Psychiatry and Clinical Neuroscience
- Vol. 241 (6) , 337-344
Abstract
The anxiogenic effects of yohimbine, a specific alpha-2-receptor antagonist were examined by administering 20 mg yohimbine orally to 8 panic patients on placebo treatment, 7 panic patients on alprazolam treatment and 12 controls using a double-blind randomized design, instructions that minimized the expectancy of experiencing a panic attack and two additional structured situations. Yohimbine induced more pronounced increases in anxiety and panicky ratings, norepinephrine secretion, maximum heart rate and high heart rate variability and decreases in skin temperature in panic patients compared with controls. However, possibly owing to an instructional set and experimental, design that distracted patients from unpleasant bodily sensations no panic attacks were observed.Keywords
This publication has 46 references indexed in Scilit:
- Autonomic Correlates of Sensation Seeking and Monoamine Oxidase Activity: Using Confirmatory Factor Analysis on Psychophysiological DataPsychophysiology, 1986
- A cognitive approach to panicBehaviour Research and Therapy, 1986
- Panic Symptoms after Inhalation of CarbondioxideThe British Journal of Psychiatry, 1984
- A Comparison of Lactate and Isoproterenol Anxiety StatesPsychopathology, 1984
- Psychophysiological Factors in Panic DisorderPsychopathology, 1984
- Fear and Anxiety: Relationship to Noradrenergic FunctionPsychopathology, 1984
- Yohimbine induced anxiety and increased noradrenergic function in humans: Effects of diazepam and clonidineLife Sciences, 1983
- Panic DisordersJournal of Clinical Psychopharmacology, 1982
- A Rating Instrument For Anxiety DisordersPsychosomatics, 1971
- Yohimbine as an Autonomic Test DrugNature, 1962